THE CAPITALYST

Resilience, Reinvention, and Revolution: Persian Entrepreneur Maky Zanganeh’s Journey from Cancer Survivor to Pharma Billionaire

Maky Zanganeh, Persian entrepreneur and cancer survivor, transformed from dentistry and robotic surgery to biotech leadership. Fleeing Iran’s revolution, she invested in Pharmacyclics in 2004, rising to COO and driving Imbruvica’s blockbuster success, culminating in AbbVie’s $21 billion acquisition. As Summit Therapeutics Co-CEO, her ivonescimab bet propelled shares 17-fold, minting her billionaire status amid oncology innovation.

The Invisible Empire: How the Billionaire Cargill-MacMillan Dynasty Quietly Feeds & Shapes the World’s Food Industry

The Cargill-MacMillan dynasty quietly dominates global agribusiness through Cargill, Inc., founded in 1865 by William W. Cargill as an Iowa grain elevator. Family marriages, like Edna Cargill to John MacMillan Sr., solidified control, expanding into feed, oilseeds, meat, and shipping despite Depression-era risks. Today, 88% family-owned with 14 billionaires, this private giant processes 25% of U.S. grain, shaping food supply chains invisibly.

Engines of Security: How Rolls-Royce Powers the Future of Global Defense

Rolls-Royce powers global defense with EJ200 engines in Eurofighter Typhoons, LiftSystem for F-35 Lightning II, and MT7 turboshafts for U.S. Navy LCS. Its mtu diesel generators equip submarines, tanks, and naval vessels, while $1B U.S. investments boost production for NATO’s 2% GDP pledges amid rising threats.

KKR: The Powerhouse Stitching a New Era in Global Healthcare

KKR pioneers a new era in global private equity, managing $553B across buyouts, credit, infrastructure, and insurance via Global Atlantic. Co-CEOs Scott Nuttall and Joseph Bae target $1T AUM by 2030 through ownership strategies, employee equity, and AI energy bets like $50B data center partnerships.